Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell differentiation in acute myeloid leukemia

I Olsson1, G Bergh, M Ehinger

  • 1Department of Medicine, University Hospital, Lund, Sweden.

European Journal of Haematology
|July 1, 1996
PubMed
Summary

Differentiation therapy can reverse maturation arrest in acute myeloid leukemia (AML), potentially improving cure rates with chemotherapy. Further research into specific molecular defects is crucial for developing optimal AML treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.

Leukemia·2020
Same author

Effects of dry period length on milk production and energy balance in two cow breeds.

Animal : an international journal of animal bioscience·2017
Same author

The DEK oncoprotein and its emerging roles in gene regulation.

Leukemia·2015
Same author

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.

Blood cancer journal·2014
Same author

Genetic relationships between growth characters in Salix viminalis grown in Sweden.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Components of resistance of leaf rust (Melamspora laricii epitea Kleb./Melampsora ribesii-viminalis Kleb.) in Salix viminalis L.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myeloid leukemia (AML) is marked by a differentiation block, leading to immature cell accumulation.
  • Chromosomal translocations in AML disrupt transcription factors essential for myeloid differentiation.
  • Aberrant gene regulation by these factors contributes to AML pathogenesis and proliferation.

Purpose of the Study:

  • To explore the potential of reversing AML maturation arrest through differentiation therapy.
  • To investigate the role of tumor suppressor genes (p53, Rb) in AML pathogenesis and differentiation.
  • To identify optimal treatment strategies by understanding AML subgroup-specific molecular defects.

Main Methods:

  • Analysis of myeloid leukemic cell lines.

Related Experiment Videos

  • Review of treatment outcomes in acute promyelocytic leukemia (APL) patients with all-trans retinoic acid.
  • Examination of the effects of manipulating p53 and Rb tumor suppressor genes.

    • Main Results:

    • Maturation arrest in AML can be reversed by specific agents, as demonstrated in cell lines and APL treatment.
    • Inactivation of p53 and Rb tumor suppressor genes is implicated in leukemia development.
    • Differentiation therapy can reduce leukemic cell mass, aiding normal hematopoiesis and remission, but not providing a cure.

    Conclusions:

    • Reversing AML maturation arrest can enhance chemotherapy effectiveness and improve cure probability.
    • Targeting specific molecular defects in AML subgroups is essential for personalized treatment.
    • Optimal AML treatment likely involves a combination of cell cycle blockade, differentiation induction, apoptosis, and immune response enhancement.